Elevated serum fibrinogen and decreased serum albumin levels are widely recognized as effective biomarkers for detecting elevated systemic inflammation.[75,83] According to research conducted by Xie et al[84], a high FAR could indicate more aggressive tumor biological characteristics as well as progressive systemic inflammation. The gene discussed is ALB; the disease is neoplasm.